MeSH D001714 - bipolar disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000068105:Bipolar and related disorders
0 Companies
0 Drugs
Success rate
D001714:
Bipolar disorder
Events Timeline
No data
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Carbamazepine | Carbamazepine | 2012-09-20 | |||
| Clozapine | Clozapine | 1997-11-26 | ||||
| Carbamazepine | Epitol | 1986-09-17 | ||||
| Gabapentin | Gabapentin | 2004-10-08 | ||||
| Lamotrigine | Lamotrigine | 2006-08-30 | ||||
| Lurasidone | Lurasidone | 2019-05-17 | ||||
| Olanzapine | Olanzapine | 2011-10-24 | ||||
| Olanzapine, Fluoxetine | Olanzapine Fluoxetine | 2012-06-19 | ||||
| Olanzapine | Olanzapine Teva | 2007-12-12 | ||||
| Paliperidone | Paliperidone | 2021-07-06 | ||||
| Quetiapine | Quetiapine | 2012-03-27 | ||||
| Topiramate | Topiramate | 2009-03-27 | ||||
| Risperidone | Uzedy | 2025-01-12 | 2023-04-28 | |||
| Risperidone | Risperidone | 2023-12-05 | ||||
| Novast Laboratories | Quetiapine | Quetiapine | 2017-11-29 | |||
| Carbamazepine | Carbamazepine | 2022-12-02 | ||||
| Taro Pharmaceutical | Carbamazepine | Carbamazepine | 1996-10-03 | |||
| Gabapentin | Gabapentin | 2013-07-03 | ||||
| Lamotrigine | Lamotrigine | 2009-01-27 | ||||
| Risperidone | Risperidone | 2011-02-07 | ||||
| Carbamazepine | Teril | 2003-09-26 | ||||
| Glenmark Pharmaceuticals | Gabapentin | Gabapentin | 2006-08-18 | |||
| Lamotrigine | Lamotrigine | 2009-02-19 | ||||
| Lithium | Lithium | 2009-02-03 | ||||
| Olanzapine | Olazax | 2009-12-11 | ||||
| Olanzapine | Olazax Disperzi | 2009-12-10 | ||||
| Topiramate | Topiramate | 2009-03-27 | ||||
| Mylan | Aripiprazole | Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) | 2015-06-30 | |||
| Clozapine | Clozapine | 1999-05-27 | ||||
| Gabapentin | Gabapentin | 2011-02-14 | ||||
| Lamotrigine | Lamotrigine | 2009-01-22 | ||||
| Lithium | Lithium | 2002-06-27 | ||||
| Olanzapine | Olanzapine | 2014-05-12 | ||||
| Olanzapine | Olanzapine Mylan | 2008-10-06 | ||||
| Quetiapine | Quetiapine | 2012-03-27 | ||||
| NATCO Pharma | Lamotrigine | Lamotrigine | 2009-01-27 | |||
| Olanzapine | Olanzapine | 2012-04-23 | ||||
| Topiramate | Topiramate | 2009-03-27 | ||||
| Johnson & Johnson | Paliperidone | Byannli (previously Paliperidone Janssen-Cilag International) | 2020-06-18 | |||
| Paliperidone | Invega | 2006-12-19 | $4,222 M | Y2024 | ||
| Paliperidone | Invega Hafyera | 2036-04-05 | 2015-05-18 | |||
| Paliperidone | Invega Sustenna | 2031-01-26 | 2009-07-31 | |||
| Risperidone | Risperdal | 1993-12-29 | $374 M | Y2022 | ||
| Topiramate | Topamax | 1996-12-24 | ||||
| Paliperidone | Trevicta (previously Paliperidone Janssen) | 2014-12-05 | ||||
| Paliperidone | Xeplion | 2011-03-04 | ||||
| GSK | Lamotrigine | Lamictal | 1994-12-27 | |||
| Cipla | Gabapentin | Gabapentin | 2009-12-30 | |||
| Lurasidone | Lurasidone | 2019-01-03 | ||||
| Olanzapine | Olanzapine Cipla (previously Olanzapine Neopharma) | 2007-11-14 | ||||
| Topiramate | Topiramate | 2009-03-27 |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
85%40/47
Phase 2
51%45/88
Phase 3
69%65/94
Approved: 24Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use